Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Am J Transplant. 2017 Nov 1;18(4):843–854. doi: 10.1111/ajt.14523

Figure 1. Treatment of the kidney graft with CD47mAb improves posttransplant survival rate in two rat DCD renal transplant models.

Figure 1

(A) Syngeneic kidney transplant model, Kaplan-Meir survival analysis of the study group showed an increase in CD47mAb group survival. (B) Allogeneic renal transplant model, also showed an increase in CD47mAb group survival.